Neurogene Inc. (NASDAQ: NGNE) Stock Information | RedChip

Neurogene Inc. (NASDAQ: NGNE) Listen to this Section


$34.84
-0.7800 ( -2.19% ) 45.2K

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Market Data


Open


$34.84

Previous close


$35.62

Volume


45.2K

Market cap


$455.04M

Day range


$34.50 - $36.92

52 week range


$12.49 - $53.00

Insider Ownership Transactions

Total Amount Purchased: -214,876.00 | $ -7,486,279.84

Date Type Amount Purchased Purchaser
2024-06-17 Sale -7700.00 PALEKAR ROHAN
2024-06-17 Sale -7700.00 Noonberg Sarah B.
2024-06-17 Sale -7700.00 BAFFI ROBERT
2024-06-17 Sale -7700.00 Woods Robert Keith
2024-06-17 Sale -7700.00 Freedland Cory S.
2024-03-14 Sale -20391.00 Cobb Stuart
2024-03-14 Sale -31903.00 Cvijic Christine Mikail
2024-03-14 Sale -93282.00 McMinn Rachel
2024-01-18 Sale -15400.00 Woods Robert Keith
2024-01-18 Sale -15400.00 Freedland Cory S.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 53 Aug 09, 2024
10-q Quarterly Reports 78 Aug 09, 2024
8-k 8K-related 15 Aug 07, 2024
8-k 8K-related 51 Jun 21, 2024
8-k 8K-related 15 Jun 18, 2024
4 Insider transactions 1 Jun 17, 2024
8-k 8K-related 13 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.